SoftOx Solutions AS (FRA:6FV)
0.0050
0.00 (0.00%)
At close: Nov 28, 2025
SoftOx Solutions AS Company Description
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections.
It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norway.
SoftOx Solutions AS
| Country | Norway |
| Founded | 2012 |
| Industry | Pharmaceutical Preparations |
| Employees | 2 |
| CEO | Thomas Bjarnsholt |
Contact Details
Address: Martin Linges vei 25 Fornebu, 1364 Norway | |
| Phone | 47 91 87 61 65 |
| Website | soft-ox.com |
Stock Details
| Ticker Symbol | 6FV |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Thomas Bjarnsholt | Chief Executive Officer |
| Ingrid Juven | Chief Financial Officer |
| Ingrid Juven | Chief Operating Officer |